Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
COSTS AND EXPENSES:        
Research and development $ 5,217 $ 1,637 $ 12,842 $ 3,322
General and administrative 2,217 1,455 5,810 3,857
Total operating expenses 7,434 3,092 18,652 7,179
Operating loss (7,434) (3,092) (18,652) (7,179)
Interest and other financing costs, net 15 2 25 2
NET LOSS $ (7,419) $ (3,090) $ (18,627) $ (7,177)
Net loss per common share, basic and diluted (in dollars per share) $ (0.71) $ (0.87) $ (1.92) $ (2.73)
Weighted average common shares outstanding, basic and diluted (in shares) 10,496,504 3,537,490 9,719,142 2,632,777